Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank93
3Y CAGR+4.3%
5Y CAGR+3.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+4.3%/yr
vs -2.8%/yr prior
5Y CAGR
+3.3%/yr
Consistent
Acceleration
+7.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$699.70M-2.4%
2024$716.98M+9.2%
2023$656.64M+6.5%
2022$616.32M-3.3%
2021$637.45M+7.2%
2020$594.53M-13.5%
2019$687.60M-0.5%
2018$690.75M+10.7%
2017$624.10M+37.0%
2016$455.63M-